Series A

HK PHARMACEUTICALS RAISES $3 MILLION IN SERIES A FINANCING

SAN DIEGO, April 30, 2003 HK Pharmaceuticals™, Inc. today announced that it has completed a $3 million Series A Preferred Equity Financing with participation by private investors from the U.S. and Europe. The Company will use the equity raised to further develop its core protein analysis CCMS™ technology that has already shown exemplary results in the discovery of new potential drug targets/biomarkers and the investigation of proteins that cause toxic side effects in existing drugs.